Category: Disclosures

[Disclosure] Hyundai Motor (005380) – Resumption of Production / 2024-02-14

February 14, 2024August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor resumed vehicle production at its Asan plant on February 14, 2024, following the completion of facility construction for electric vehicle (EV) production. 📊 [Key Disclosure Content & Financial Highlights] 1. Area and Details of Resumption 2. Suspension Period & Resumption Date 3. Reason for…

Disclosures, Automotive

[Disclosure] Samsung Biologics (207940) – Decision on General Meeting of Shareholders / 2024-02-14

February 14, 2024August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has resolved to hold its 13th Annual General Meeting of Shareholders on March 15, 2024, to submit agenda items including the approval of FY2023 financial statements and the approval of the limit on director remuneration. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] SK Square (402340) – Clarification to Rumors or Reports (Unconfirmed) / 2024-02-08

February 8, 2024July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has re-disclosed regarding reports on the sale of its subsidiary 11Street that financial investors are pursuing the process via drag-along rights, but specific terms and transaction amounts remain unconfirmed. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Semiconductors, Disclosures

[Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2024-02-08

February 8, 2024August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary LEENO Industrial has resolved on a year-end cash dividend of KRW 3,000 per common share for FY2023, totaling approximately KRW 45.54 billion. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of AGM Approval and Scheduled Payment Date The company…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – (Correction) Result of Measures Taken Due to Accounting Standards Violation / 2024-02-08

February 8, 2024August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has submitted a corrected disclosure following receipt of the written judgment, adding detailed specifics on its first-instance acquittal regarding alleged accounting standards violations for FY2014 and FY2015. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Prosecution Appeal…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Measures Taken Due to Accounting Standards Violation / 2024-02-08

February 8, 2024August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed that it confirmed an appeal filed by the Seoul Central District Prosecutors’ Office against the first-instance acquittal on charges of accounting standards violations. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Legal Proceedings and Final…

Disclosures, Bio & Healthcare

[Disclosure] PSK Holdings (031980) – Decision on Calling of General Shareholders’ Meeting / 2024-02-07

February 7, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary PSK Holdings will convene its Annual General Meeting of Shareholders on March 29, 2024, to vote on agendas including the approval of FY34 financial statements (KRW 600 dividend per share), amendments to Articles of Incorporation, and new appointments of Inside Director Jin-kyung Park and Independent Director…

Semiconductors, Disclosures

[Disclosure] PSK Holdings (031980) – Decision on Cash/In-Kind Dividend / 2024-02-07

February 7, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary PSK Holdings decided to pay a year-end cash dividend of KRW 600 per common share for FY2023, totaling approximately KRW 12.94B with a dividend yield of 2.2%. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Final Dividend…

Semiconductors, Disclosures

[Disclosure] PSK Holdings (031980) – Change in Revenue or Income Structure Exceeding 30% (15% for Large Corporations) / 2024-02-07

February 7, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Driven by expanding HBM demand and growth in the advanced packaging market, PSK Holdings reported FY2023 consolidated revenue of KRW 94.72B (+30.1% YoY) and operating profit of KRW 27.13B (+60.5% YoY). 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Semiconductors, Disclosures

[Disclosure] PSK Holdings (031980) – Report on Reason for Holding Shareholders’ Meeting on Peak Concentration Day / 2024-02-07

February 7, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary PSK Holdings reported its reason for scheduling the 34th Annual General Meeting of Shareholders on March 29, 2024, a designated peak concentration day, due to internal closing schedules and audit report receipt timelines. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up…

Semiconductors, Disclosures